Skip to main content

Table 1 Characteristics of the 420 Patients Enrolled in the Stroke Outcome Study from 2001–2002 at the Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada

From: Medication Persistence Rates and Factors Associated with Persistence in Patients Following Stroke: A Cohort Study

Characteristic n (%)a
Sex  
   Male 234 (55.7)
   Female 186 (44.3)
Age (years) 68.2 ± 13.8
   < 65 138 (32.9)
   65–79 198 (47.1)
   ≥ 80 84 (20.0)
History of previous stroke (n = 418) 109 (26.1)
Length of hospital stay (days) 16.2 ± 21.1
Stroke subtype  
   Partial anterior circulation 132 (31.4)
   Lacunar 106 (25.2)
   Posterior circulation 79 (18.8)
   Total anterior circulation 30 (7.1)
   Transient ischemic attack 59 (14.0)
   Uncertain 14 (3.3)
Stroke severity  
   Transient ischemic attack 35 (8.4)
   Mild 90 (21.5)
   Moderate 226 (53.9)
   Severe 68 (16.2)
   Unknown 1 (0.002)
Disability at discharge  
   Independent 333 (79.3)
   Dependent 87 (20.7)
Cognitive impairment at discharge  
   Not impaired 111 (26.4)
   Impaired 84 (20.0)
   Missing 225 (53.6)
Atrial fibrillation (n = 418) 60 (14.4)
Average household income (n = 386) $55,472 ± 19,370
Total medications prescribedb 6.4 ± 2.6
Total doses taken per dayb 8.6 ± 4.5
Monthly cost of prescription drugsc $167.10 ± 99.47
  1. aValues expressed as number (%) or mean ± standard deviation, n = 420 unless otherwise noted
  2. bIncludes all prescription and non-prescription medications ordered by a physician at time of discharge
  3. cIncludes only community prescription drug costs at time of discharge excluding pharmacist's professional fees